About Us

Supriya Lifescience Limited headquartered in Mumbai, India is a public listed generic pharmaceutical company established in 1987 dedicated to developing, commercializing APIs & FDFs to treat patients with various diseases and infections. The API facility located at Lote, Maharashtra, India is multiple times USFDA, EDQM/EUGMP approved, and Health Canada approved.

Read More Watch Video

Area of Focus

API

FDF

CDMO
40+

Products

86+

Countries

1500+

Customers

22%

& above CAGR since 2019

400+

Employee Strength

We have a global footprint that extends across 86 countries

APIs

FDF

Awards

Latest News

10 December 2024

Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval & Atorvastatin patent filing

Read More

10 December 2024

Supriya Lifescience gains ANVISA nod for Esketamine Hydrochloride & files patent for Atorvastatin development

Read More

09 December 2024

Supriya Lifescience Gets Brazil's Nod For Mental Illness Drug

Read More

09 December 2024

Supriya Lifescience gets Brazil approval for mental illness drug, files patent for heart & cholestrol medicine

Read More

09 December 2024

With the approval of esketamine hydrochloride and the application

Read More

11 November 2024

Supriya Lifescience Receives 'Buy' Rating After Positive Financial Results

Read More

07 November 2024

Supriya Lifescience Ltd. Reports Strong Q2 FY25 Growth With 19% YoY Revenue Increase

Read More

01 November 2024

Supriya Lifescience reports 19% revenue increase in Q2 FY25

Read More

30 October 2024

Supriya Lifescience Second Quarter 2025 Earnings: EPS: ₹5.71 (vs ₹2.97 in 2Q 2024)

Read More

29 October 2024

Supriya Lifescience: A Promising Smallcap Pharma Stock with Strong Financials and Positive Market Performance

Read More

29 October 2024

Supriya Lifescience Q2 Revenue Up 19%, Driven By Anaesthetic Segment

Read More

Several awards for excellence and outstanding performance.

Established in the year 1987, Supriya Lifescience Ltd. is a global leading manufacturer of Active pharmaceutical Ingredients. Our state-of-the-art facility is certified by USFDA, EDQM, EUGMP, NMPA & Health Canada. Facility is located in Khed, District Ratnagiri and headquartered in Mumbai, India.

Read More
BSE
NSE